Literature DB >> 6725257

Mouse antibodies to the insulin receptor developing spontaneously as anti-idiotypes. II. Effects on glucose homeostasis and the insulin receptor.

D Elias, R Maron, I R Cohen, Y Schechter.   

Abstract

Mice immunized to bovine insulin were observed to develop anti-idiotypic antibodies which behaved in in vitro assays as antibodies to the insulin receptor. The studies described here were undertaken to investigate the effects of these antibodies in vivo on the physiology of glucose homeostasis and the state of insulin receptors. Mice developing anti-idiotypic receptor antibodies manifested abnormal fasting blood glucose concentrations: a period of hypoglycemia followed by a period of hyperglycemia. Moreover, the mice were deficient in their ability to respond to a glucose load. Changes in the number and activity of insulin receptors were associated with these physiological aberrations. In an insulin binding assay, adipocytes obtained from immunized mice had only 40% of the number of insulin receptors demonstrable on the adipocytes of control mice. The lipogenic response of the affected adipocytes was also relatively insensitive to insulin, and in addition, they manifested only 70% of the maximal response to high concentrations of insulin. Thus, development of anti-idiotypic receptor antibodies appeared to be associated with insulin resistance of adipocytes and abnormal glucose homeostasis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6725257

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action.

Authors:  R De Pirro; P Borboni; M A Marini; A Montemurro; G Sesti; R Lauro
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

2.  Mice immunized with measles virus develop antibodies to a cell surface receptor for binding virus.

Authors:  D L Krah; P W Choppin
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

Review 3.  Autoantigen complementarity: a new theory implicating complementary proteins as initiators of autoimmune disease.

Authors:  William F Pendergraft; Barrak M Pressler; J Charles Jennette; Ronald J Falk; Gloria A Preston
Journal:  J Mol Med (Berl)       Date:  2004-12-11       Impact factor: 4.599

4.  Desensitization of the insulin receptor by antireceptor antibodies in vivo is blocked by treatment of mice with beta-adrenergic agonists.

Authors:  D Elias; M Rapoport; I R Cohen; Y Shechter
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

5.  Immunocytochemistry of magnocellular neurons of supraoptic and paraventricular nuclei of normal and Brattleboro rats with vasopressin anti-idiotype antibody.

Authors:  K M Knigge; D T Piekut; D J Berlove
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

6.  Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein.

Authors:  D Elias; D Markovits; T Reshef; R van der Zee; I R Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

7.  Circulating lymphocyte populations and autoantibodies in non-obese diabetic (NOD) mice: a longitudinal study.

Authors:  O Pontesilli; P Carotenuto; L S Gazda; P F Pratt; S J Prowse
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

8.  Autoantibodies to the insulin receptor are infrequent findings in type 1 (insulin-dependent) diabetes mellitus of recent onset.

Authors:  N Rochet; J L Sadoul; B Ferrua; J Kubar; J F Tanti; P Bougnères; B Vialettes; E Van Obberghen; Y Le Marchand-Brustel; P Freychet
Journal:  Diabetologia       Date:  1990-07       Impact factor: 10.122

9.  The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes.

Authors:  Shilpa Oak; Lisa K Gilliam; Mona Landin-Olsson; Carina Törn; Ingrid Kockum; Christina R Pennington; Merrill J Rowley; Michael R Christie; J Paul Banga; Christiane S Hampe
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-26       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.